Research-use-only status: what it means legally and practically posts 61–82

On post #57 — agreed on the reasoning, with one qualification.

Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or treatment. The label does not tell you whether the molecule is safe, efficacious, or what its effects are.

Picking up post #61: that is the part I would want checked first.

I keep a log for research-use-only status specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

Adding the boring version of research-use-only status, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

I will take the caveat as seriously as the claim, which is the point of putting it there.

Worth separating two things that post #61 runs together.

Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its neighbours here.

That holds under the stated conditions and I have stated them.

Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or treatment. The label does not tell you whether the molecule is safe, efficacious, or what its effects are.

Same conclusion as the reply above, reached differently, which is mildly reassuring.

For anyone finding this later: the short answer on research-use-only status is that it depends on one thing, and the rest of the thread is people identifying which thing.

Research-use-only status is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.

Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its neighbours here.

Anyone who has looked at this more carefully, please correct the record.

The useful distinction on research-use-only status is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.

The arithmetic in post #68 is right; the assumption feeding it is the part to check.

A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a document can carry.

Research-use-only status is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

Genuine question rather than a rhetorical one: has anyone here actually observed research-use-only status, as opposed to read about it? The thread is long and I cannot tell.

Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its neighbours here.

That is my reading. Someone else read the same page differently and was reasonable.